Ryota Kikuchi, DMD
Clinical Assistant Professor
Boston University Henry M. Goldman School of Dental Medicine
General Dentistry

DMD, Henry M. Goldman School of Dental Medicine - BU
DDS, Nihon University
CAGS, Henry M. Goldman School of Dental Medicine - BU



Dr. Ryota Kikuchi received a Certificate in Advanced Graduate Study in Advanced Education in General Dentistry from the Boston University Henry M. Goldman School of Dental Medicine in 2007. He was awarded the Excellent Clinician Award in his program in 2007. He received a DDS from Nihon University School of Dentistry in Tokyo Japan in 1998. While in Tokyo, Dr. Kikuchi practiced General Dentistry at the Yorozuya Dental Office from 1998 to 2006.

He graduated from DMD Advance Standing program in 2012 with high honors and became a member of OKU. He start working as a clinical assistant professor at BUGSDM in Department of General Dentistry since 2012 and became a Group Practice Leader in 2013. He received the excellence in teaching award from DMD students of 2013 and 2014.

He maintains the full-time faculty position at BUGSDM as he’s passionate about teaching future dentists to provide quality oral health care.

Practice Leader, Predoctoral Patient Treatment Center
Boston University Henry M. Goldman School of Dental Medicine
Group Practice
SDM Group Practice

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kikuchi R, Watanabe Y, Okuma T, Nakamura H, Abe S. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities. Cancer Immunol Immunother. 2024 Sep 05; 73(11):211. PMID: 39235641; PMCID: PMC11377385; DOI: 10.1007/s00262-024-03792-5;
     
  2. Shioiri N, Kikuchi R, Matsumoto I, Furukawa K, Kobayashi K, Abe S. Effective treatment of steroid-resistant immune checkpoint inhibitor pneumonitis with mycophenolate mofetil. Respirol Case Rep. 2024 Apr; 12(4):e01356. PMID: 38623524; PMCID: PMC11018367; DOI: 10.1002/rcr2.1356;
     
  3. Ishiwari M, Kono Y, Togashi Y, Kobayashi K, Kikuchi R, Kogami M, Abe S. Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26; 41(1):e2024002. PMID: 38567555; PMCID: PMC11008323; DOI: 10.36141/svdld.v41i1.15264;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 3 publications over 1 distinct years, with a maximum of 3 publications in 2024

YearPublications
20243

Contact for Mentoring:

100 E. Newton St Goldman SDM
Boston MA 02118
Google Map


Kikuchi's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department